Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thymiverlan is a traditional herbal medicine developed and marketed by Verla-Pharm Arzneimittel. It is formulated as an oral liquid containing thyme herb fluid extract (Thymiankraut-Fluidextrakt) as its active ingredient. Thymiverlan is indicated for the relief of productive coughs and mucus dissolution associated with common colds and respiratory tract infections. The active components of thyme, such as thymol and carvacrol, exert secretolytic, bronchospasmolytic, and anti-inflammatory effects, helping to liquefy viscous mucus in the bronchi and facilitate expectoration. It is approved and marketed in Germany as an over-the-counter (OTC) product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thyme herb fluid extract.